Pharmaceutical Grade Trimetazidine Dihydrochloride Coa Gmp Standard
- [Chemical Architecture]: Validated synthesis routes ensuring high yield and minimal impurity profiles for 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine dihydrochloride.
- [Procurement Stability]: Factory-direct bulk pricing and tonnage availability with batch-specific documentation for seamless supply chain integration.
- [Regulatory Framework]: Production facilities operating under strict GMP standard protocols to meet international pharmacopeia requirements for cardiac medications.
In the competitive landscape of cardiovascular pharmaceuticals, securing a reliable source of high-purity intermediates is critical for maintaining production schedules and product efficacy. Trimetazidine Dihydrochloride (CAS: 13171-25-0) serves as a vital anti-ischemic metabolic agent, widely utilized in the formulation of treatments for stable angina pectoris. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. delivers this essential compound with a focus on process-scale purity and regulatory adherence.
Our commitment extends beyond simple distribution; we provide comprehensive technical support and quality assurance to ensure every batch meets the rigorous demands of modern API synthesis. Whether for R&D scale-up or commercial tonnage, our facility is equipped to handle complex requirements with precision.
Interpreting Certificate Of Analysis Data
For procurement specialists and quality control managers, the Certificate of Analysis (COA) is the cornerstone of vendor validation. When evaluating pharmaceutical grade materials, it is imperative to scrutinize not just the final purity percentage, but the specific impurity profile listed in the documentation. Our COAs provide detailed breakdowns of related substances, residual solvents, and heavy metals, ensuring transparency.
Buyers sourcing Trimetazidine Dihydrochloride should verify that the provided COA aligns with their internal specifications for molecular weight and identity confirmation. We ensure that every shipment is accompanied by a batch-specific COA, allowing for immediate QC verification upon receipt. This level of documentation reduces downtime in your production line and mitigates the risk of regulatory queries during audits.
GMP Compliance In Production Facilities
Executive decision-makers must prioritize suppliers who demonstrate robust quality management systems. Production of cardiac agents requires an environment that minimizes cross-contamination and ensures batch-to-batch consistency. NINGBO INNO PHARMCHEM CO.,LTD. operates facilities designed to meet GMP standard expectations, incorporating strict environmental controls and standardized operating procedures.
Adherence to these standards is not merely about certification; it is about risk mitigation. A compliant supply chain protects your brand reputation and ensures commercial viability in regulated markets. Our quality assurance teams conduct regular internal audits and stability testing to guarantee that the industrial purity of our output remains consistent over time, regardless of order volume.
Technical Specifications Overview
| Parameter | Specification |
|---|---|
| Product Name | Trimetazidine Dihydrochloride |
| CAS Number | 13171-25-0 |
| Molecular Formula | C14H24Cl2N2O3 |
| Molecular Weight | 339.26 g/mol |
| IUPAC Name | 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride |
| Purity Standard | >98.5% (HPLC) |
| Storage Conditions | Sealed, dry, +5°C to 25°C |
Impurity Profiling And Safety Standards
For process chemists and R&D teams, understanding the synthesis route is essential for anticipating potential impurities. The manufacturing process for this compound involves precise alkylation and salt formation steps. Residual starting materials or side-products from the piperazine ring formation must be tightly controlled to meet safety standards.
Our technical team utilizes advanced chromatographic methods to profile impurities at trace levels. This data is crucial for toxicity assessments and regulatory filings. By maintaining tight control over the reaction parameters, we ensure that the final product supports the metabolic mechanism of action required for anti-anginal efficacy without introducing confounding variables from synthetic byproducts.
Reliable access to high-quality intermediates is the backbone of efficient pharmaceutical manufacturing. To proceed with your procurement process, please contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote.